BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6206101)

  • 1. Epithelial membrane antigen in cells from the uterine cervix: immunocytochemical staining of cervical smears.
    Valkova B; Ormerod MG; Moncrieff D; Coleman DV
    J Clin Pathol; 1984 Sep; 37(9):984-9. PubMed ID: 6206101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical staining of cervical smears for the diagnosis of cervical intraepithelial neoplasia.
    Moncrieff D; Ormerod MG; Coleman DV
    Anal Quant Cytol; 1984 Sep; 6(3):201-5. PubMed ID: 6391321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated screening of cervical smears using immunocytochemical staining: a possible approach.
    Valkova B; Laurence DJ
    J Clin Pathol; 1985 Aug; 38(8):886-92. PubMed ID: 2411765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor marker studies of cervical smears. Potential for automation.
    Moncrieff D; Ormerod MG; Coleman DV
    Acta Cytol; 1984; 28(4):407-10. PubMed ID: 6205530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of immunohistochemical markers in the diagnosis of cervical neoplasia.
    Fray RE; Husain OA; To AC; Watts KC; Lader S; Rogers GT; Taylor-Papadimitriou J; Morris NF
    Br J Obstet Gynaecol; 1984 Oct; 91(10):1037-41. PubMed ID: 6386038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical wart virus infection, intraepithelial neoplasia and carcinoma; an immunohistological study using a panel of monoclonal antibodies.
    Morris HB; Gatter KC; Pulford K; Haynes P; Charnock M; Taylor-Papadimitriou J; Lane EB; Mason DY
    Br J Obstet Gynaecol; 1983 Nov; 90(11):1069-81. PubMed ID: 6315048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical carcinoma antigen: distribution in neoplastic lesions of the uterine cervix and comparison to other tumor markers.
    Flint A; McCoy JP; Schade WJ; Hofheinz DA; Haines HG
    Gynecol Oncol; 1988 May; 30(1):63-70. PubMed ID: 2452772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor marker studies of cervical smears: an immunohistochemical approach.
    Sarker AB; Koirala TR; Nose S; Jeon HJ; Hoshida Y
    Indian J Pathol Microbiol; 1994 Jan; 37(1):45-51. PubMed ID: 7522221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of Ca antigen in normal, dysplastic and neoplastic squamous epithelia of the human uterine cervix.
    Lloyd JM; O'Dowd T; Driver M; Tee DE
    J Clin Pathol; 1984 Jan; 37(1):14-9. PubMed ID: 6368596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of epithelial antigens in the human uterine cervix: a review.
    Serra V; Ramirez A; Marzo MC; Valcuende F; Lara C; Castells A; Bonilla-Musoles F
    Arch Gynecol Obstet; 1989; 246(2):61-84. PubMed ID: 2684044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies for the histopathological diagnosis of cervical neoplasia.
    Jha RS; Wickenden C; Anderson MC; Coleman DV
    Br J Obstet Gynaecol; 1984 May; 91(5):483-8. PubMed ID: 6202315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An immunohistochemical study of the distribution of epithelial membrane antigen (EMA) in uterine carcinoma].
    Fukuda K; Fujimoto I; Masubuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):739-45. PubMed ID: 3598270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards an automated procedure for the quantitative cytological screening of cervical neoplasms.
    Sincock AM; Middleton J; Moncrieff D
    J Clin Pathol; 1983 May; 36(5):535-8. PubMed ID: 6841647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential.
    Koizumi M; Uede T; Shijubo N; Kudo R; Hashimoto M; Kikuchi K
    Cancer Res; 1988 Nov; 48(22):6565-72. PubMed ID: 3052807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent studies directed towards the location of abnormal epithelial cells in cervical smears.
    Steven FS; Johnson J
    Cytopathology; 1990; 1(4):217-22. PubMed ID: 1714306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.
    Dixon EP; King LM; Nelson R; Simkins SG; Knapp SL; Brough GH; Lenz KL; Henderson DT; Whitehead CM; Hessling J; Brown CA; Malinowski DP
    J Immunol Methods; 2017 Mar; 442():35-41. PubMed ID: 28093271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAPNET for analysis of proliferating (MIB-1 positive) cell populations in cervical smears.
    Boon ME; Kleinschmidt-Guy ED; Ouwerkerk-Noordam E
    Eur J Morphol; 1994 Mar; 32(1):78-85. PubMed ID: 8086271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the CD 15 antigen is a marker of cellular differentiation in cervical intra-epithelial neoplasia (CIN).
    Sanders DS; Kerr MA; Hopwood D; Coghill G
    J Pathol; 1988 Jul; 155(3):207-12. PubMed ID: 3411381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of an epitope of the transferrin receptor in human cervical epithelium--a potentially useful cell marker.
    Lloyd JM; O'Dowd T; Driver M; Tee DE
    J Clin Pathol; 1984 Feb; 37(2):131-5. PubMed ID: 6198338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2.
    Heyderman E; Strudley I; Powell G; Richardson TC; Cordell JL; Mason DY
    Br J Cancer; 1985 Sep; 52(3):355-61. PubMed ID: 3899156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.